Clinical Trials
Avance Clinical Client Atossa Therapeutics Announces Final Results from...
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical congratulated Atossa Therapeutics on the announcement of...
Clinical Trials
Valneva and Pfizer Announce Initiation of Phase 2 Study...
Valneva SE, a specialty vaccine company focused on prevention of diseases with major unmet needs, and Pfizer Inc. announced initiation of study VLA15-221. The VLA15-221...
Clinical Trials
LSK Global PS Adopts Veeva Vault Clinical Applications to...
Veeva Systems announced that LSK Global Pharma Services Co. Ltd, a leading Korean contract research organization (CRO), has adopted Veeva Vault eTMF, Veeva Vault CTMS,...
Clinical Trials
Regeneron Announces Positive Phase 2 Data Evaluating Fel d...
Regeneron Pharmaceuticals, Inc. announced detailed results from a Phase 2 proof-of-concept trial evaluating the investigational antibody cocktail REGN1908-1909 in cat-allergic patients with mild asthma. The...
Articles
The Impact of COVID-19 on Rare Disease Clinical Trials
Barriers and triumphs of an underserved patient group.
It is undeniable that clinical trials for rare diseases are more challenging to design and execute. Unlike trials...
Clinical Trials
AiCure, OncoBay Clinical Partner to Improve Patient Care, Optimize...
AiCure and OncoBay Clinical announced a partnership to provide oncology sponsors with scalable, AI-powered insights to improve patient care and optimize drug development. A subsidiary...
Clinical Trials
Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase...
Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced the complete enrollment of PREVENT-19, its pivotal Phase 3 study in the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.